TARGETING SIGNALLING PATHWAYS IN HAEMATOLOGICAL MALIGNANCIES: ARE WE CLOSE TO THE END OF HISTOPATHOL...

Conclusions: Is this the end of chemotherapy in lymphoma?

A. Rosenwald